We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Neurogen (MM) | NASDAQ:NRGN | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.1825 | 0 | 01:00:00 |
From Jun 2019 to Jun 2024
Neurogen Corporation (NASDAQ:NRGN), a drug development company, announced today that it will release its third quarter 2009 financial results on Friday, November 6, 2009 before the opening of the U.S. financial markets. The Company will host a conference call and live audio webcast that same day at 8:30 am EST to review the results.
The news release and live webcast may be accessed through the investor relations section of the Company's web site: www.neurogen.com. The webcast will also be archived in this section, under "Events Calendar and Replays."
About Neurogen
Neurogen Corporation is a drug development company historically focused on small-molecule drugs to improve the lives of patients suffering from psychiatric and neurological disorders with significant unmet medical need. Neurogen has entered into a previously announced agreement to merge into Ligand Pharmaceuticals, Inc. The merger is expected to closed by the end of 2009.
1 Year Neurogen Chart |
1 Month Neurogen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
